Who Is Seeking Help for Sleep? A Clinical Profile of Patients in a Sleep Psychology Clinic

Vallières, Annie; Pappathomas, Alric; Araújo, T.; Crawford, Megan R.; Garnier, Séverine

doi:10.1007/s12529-020-09882-9

Cited by 7 publications

(2 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 While sleep disorders are relatively common among people with mental disorders, they are also often a reason for health care contact in their own right. 4 Sleep disorders have been associated with suicidal ideation and behaviour, including suicide. [5][6][7][8] Further complicating the issue, links between medications often used as hypnotics (e.g., benzodiazepines, nonbenzodiazepines) and suicide have been observed.…”

Section: Introductionmentioning

confidence: 99%

Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study

Høier

Madsen

Spira

et al. 2022

Journal of Clinical Sleep Medicine

View full text Add to dashboard Cite

Study Objectives: Melatonin is often prescribed to patients with sleep disorders who are known to have elevated suicide risks. Yet, melatonin's association to suicidal behaviour remains to be examined. We investigated whether individuals prescribed melatonin had higher rates of suicide and suicide attempts when compared to individuals who were not prescribed this drug, including both those with and without known mental disorders. Methods:A cohort design was applied to longitudinal, register data on all persons aged 10+ years in Denmark during 2007-2016. Based on data from the National Prescription Register, periods of being in treatment with melatonin were defined using information on number of tablets and daily defined dose. We calculated IRR for suicide and suicide attempts, as identified in register records, comparing those in treatment with melatonin to those not in treatment. Results:Among 5,798,923 individuals, 10,577 (0.2%) were treated with melatonin (mean treatment length 50 days) during the study period. Of those, 22 died by suicide and 134 had at least one suicide attempt. People in treatment with melatonin had a 4-fold higher rate of suicide (IRR: 4.8; 95% CI, 3.0-7.5) and a 5-fold higher rate of suicide attempt (IRR: 5.9; 95% CI,4.4-8.0) than those not in treatment and when adjusting for sex and age-group. Conclusions:Treatment with melatonin was associated with suicide and suicide attempt. While there are several possible explanations, attention to suicide risk is particularly warranted for people with mental comorbidity who are in treatment with melatonin.

show abstract

Section: Introductionmentioning

confidence: 99%

Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study

Høier

Madsen

Spira

et al. 2022

Journal of Clinical Sleep Medicine

View full text Add to dashboard Cite

show abstract

“…Included articles illustrate work that spans major research areas theories and clinical applications. Papers in this issue span across a variety of important groups at risk for poor sleep or vulnerability to the effects of sleep disruptions, including pregnant women ( [9]; this issue), military personnel ( [10]; this issue), as well as identification of individuals at heightened risk for cancer ([11]; this issue), and disordered weight control ( [12]; this issue), or with multiple medical co-morbidities ( [13]; this issue).…”

Section: Introductionmentioning

confidence: 99%

Furthering the Focus on Translational Sleep Science in Behavioral Medicine

Hoyt

2021

Int.J. Behav. Med.

View full text Add to dashboard Cite

Translational sleep science has become a critical and fundamental focus in the field of behavioral medicine. This is the second issue in the special series of the International Journal of Behavioral Medicine focused on the physiological, psychological, social, and environmental concomitants of sleep and human health. The articles included in this issue draw further attention to the range and significance of sleep as a marker of health status and as a target of behavioral intervention. The research included in this series highlights the pervasive manner in which sleep health is intrinsically connected to health risk, behavior, and outcomes. The next decade promises to further behavioral medicine approaches to improving the provision of care and the overall public health through the implementation of translational sleep science research.

show abstract

Sleep deprivation leads to further impairment of hippocampal synaptic plasticity by suppressing melatonin secretion in the pineal gland of chronically unpredictable stress rats

Liu

Xie

et al. 2022

European Journal of Pharmacology

View full text Add to dashboard Cite

Who Is Seeking Help for Sleep? A Clinical Profile of Patients in a Sleep Psychology Clinic

Cited by 7 publications

References 41 publications

Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study

Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study

Furthering the Focus on Translational Sleep Science in Behavioral Medicine

Sleep deprivation leads to further impairment of hippocampal synaptic plasticity by suppressing melatonin secretion in the pineal gland of chronically unpredictable stress rats

Contact Info

Product

Resources

About